Recent News

• 12.12.2025 - Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy
• 11.18.2025 - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• 11.17.2025 - Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy

Recent Filings

• 12.12.2025 - 8-K Current report
• 12.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.05.2025 - 144 Report of proposed sale of securities
• 12.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2025 - 4 Statement of changes in beneficial ownership of securities